跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APIXABAN LAPL apixaban 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APIXABAN LAPL apixaban 5 mg tablet blister pack
Approved
STANDARD
APIXABAN LAPL apixaban 5 mg tablet blister pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
b7831f3df2bb7064
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
b7831f3df2bb7064
Product Name
APIXABAN LAPL apixaban 5 mg tablet blister pack
Artg Id
392234
Artg Name
APIXABAN LAPL apixaban 5 mg tablet blister pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2025-05-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
b7831f3df2bb7064
Type
Standard
Back to TGA Approvals
